US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

Leo Pharma Sues Perrigo Israel Over Generic Taclonex

By Dan Rivoli · February 16, 2011, 5:18 PM EST

Leo Pharma A/S has sued generic-drug maker Perrigo Israel Pharmaceuticals Ltd. to block it from selling its own version of the Danish company's Taclonex ointment, used to treat the skin disease...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Leo Pharma A/S v. Perrigo Isrel Pharma Ltd.

Case Number

1:11-cv-00963

Court

New York Southern

Nature of Suit

Patent

Date Filed

February 14, 2011

Featured Stories

Hospitals Lean On Payors Amid ACA, Medicaid Cuts No Photo Available

Yeji Jesse Lee

Hospitals feeling a mounting financial squeeze are getting more aggressive in contract negotiations and reimbursement disputes with in... (more story)

Meet The Atty In Colo. Hospital Gender Care Lawsuit No Photo Available

Mark Payne

Paula Greisen has represented clients in the LGBTQ+ community in major litigation over the past decade, most recently helping a group ... (more story)

Trump Not Likely to Change Direction of School Vaccine Law No Photo Available

Dan McKay

A handful of states that don't allow religious exemptions to school vaccine mandates have repeatedly prevailed in the face of legal ch... (more story)